2008Chinese Journal of Hospital PharmacyRequires access

Pharmacokinetics of lafutiding tablets in healthy volunteers

TU Nin

Open publisher page 0 citations

Abstract

OBJECTIVE To study the pharmacokinetics of lafutiding tablets in healthy volunteers.METHODS The plasma concentrations of lafutiding tablets were determined by LC-MS methods after the lafutiding tablets(10㎎) were given to the 12 healthy volunteers.RESULTS tmax was(1.3±0.4) hours.Cmax was(158.6±41.6)μg·L-1,AUC0-24 was(882.0±306.1) μg·h-1·L-1,AUC0-∞was(898.8±316.4) μg·h-1·L-1.The t1/2α of estimate was(1.45±0.14)hours.t1/2β was(4.4±0.4)hours,CL/F was(12.3±4.1) h-1.CONCLUSION The t1/2 、 Cmax、CL/F、AUC0-24and AUC0-∞ about the lafutiding tablets in male healthy volunteers is similar to the female healthy volunteers's(P0.05).tmax is different between female and male(P0.05),the results show that there was no significant difference in pharmacokinetics compared with the reported reference.

About this research paper

What this paper is about

OBJECTIVE To study the pharmacokinetics of lafutiding tablets in healthy volunteers.METHODS The plasma concentrations of lafutiding tablets were determined by LC-MS methods after the lafutiding tablets(10㎎) were given to the 12 healthy volunteers.RESULTS tmax was(1.3±0.4) hours.Cmax was(158.6±41.6)μg·L-1,AUC0-24 was(882.0±306.1) μg·h-1·L-1,AUC0-∞was(898.8±316.4) μg·h-1·L-1.The t1/2α of estimate was(1.45±0.14)hours.t1/2β was(4.4±0.4)hours,CL/F was(12.3±4.1) h-1.CONCLUSION The t1/2 、 Cmax、CL/F、AUC0-24and AUC0-∞ about the lafutiding tablets in male healthy volunteers is similar to the female healthy volunteers's(P0.05).tmax is different between female and male(P0.05),the results show that there was no significant difference in pharmacokinetics compared with the reported reference.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

OBJECTIVE To study the pharmacokinetics of lafutiding tablets in healthy volunteers.METHODS The plasma concentrations of lafutiding tablets were determined by LC-MS methods after the lafutiding tablets(10㎎) were given to the 12 healthy volunteers.RESULTS tmax was(1.3±0.4) hours.Cmax was(158.6±41.6)μg·L-1,AUC0-24 was(882.0±306.1) μg·h-1·L-1,AUC0-∞was(898.8±316.4) μg·h-1·L-1.The t1/2α of estimate was(1.45±0.14)hours.t1/2β was(4.4±0.4)hours,CL/F was(12.3±4.1) h-1.CONCLUSION The t1/2 、 Cmax、CL/F、AUC0-24and AUC0-∞ about the lafutiding tablets in male healthy volunteers is similar to the female healthy volunteers's(P0.05).tmax is different between female and male(P0.05),the results show that there was no significant difference in pharmacokinetics compared with the reported reference.

Key concepts: Pharmacokinetics, Cmax, Plasma concentration, Pharmacology, Medicine, Significant difference, Internal medicine

Related papers

Back to paper searchBrowse research topicsOriginal source
Pharmacokinetics of lafutiding tablets in healthy volunteers — Research Paper | ScholarLens